title: Novel approaches to female sexual dysfunction.
abstract: Female sexual dysfunction is age-related, progressive and highly prevalent, affecting 30 - 50% of American women. While there are emotional and relational elements to sexual function, it has become increasingly evident that female sexual dysfunction can occur secondary to medical problems and has an organic basis. A plethora of different female sexual dysfunctions exist and in order to obtain a greater understanding of the possible treatments for these problems, it is essential to have a strong knowledge base of female pelvic anatomy, the neurogenic mediators of female sexual response, the impact of hormones on female sexual function and the aetiologies of female sexual dysfunction. Currently, there are potential therapeutic options for the treatment of female sexual dysfunction and these options include both hormonal and pharmacological therapy. However, therapeutic agents may not prove to be enough and the ideal approach to female sexual dysfunction is thus a collaborative effort between therapists and physicians, which should include a complete medical and psychosocial evaluation, as well as inclusion of the partner or spouse in the evaluation and treatment process.
authors: Division of Urology, Boston University Medical Center, 720 Harrison Ave., Suite 606, Boston, MA 02110, USA. lbvenis@aol.com
authors: L A
authors: LA
authors: Berman
authors: J R
authors: JR
authors: Berman
authors: S
authors: S
authors: Chhabra
authors: I
authors: I
authors: Goldstein
mesh_terms: D002987:Clitoris / Q000033:anatomy & histology / Q000502:physiology; D004967:Estrogens / Q000502:physiology; D005260:Female; D006801:Humans; D012725:Sexual Behavior; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy* / Q000209:etiology; D013739:Testosterone / Q000502:physiology; D014599:Uterus / Q000033:anatomy & histology; D014621:Vagina / Q000033:anatomy & histology
chemical_list: D004967:Estrogens; D013739:Testosterone